Pharmacopeia Inc., of Cranbury, N.J., promoted Rene Belder to senior vice president of clinicaland regulatory affairs and S. David Kimball to senior vice president of chemistry and preclinical chemical development
InSite Vision Incorp., of Alameda, Calif., named Kamran Hosseini, vice president of clinical affairs and chief medical officer...Ovation Pharmaceuticals Inc., of Deerfield, Ill., named Christopher Silber vice president of clinical affairs
The company also named Kevin M. Forrest and R. Andrew McMillan principals...Ambrx Inc., of San Diego, appointed Douglas W. Axelrod senior vice president of clinical research and development...Solace Pharmaceuticals, of Boston, named Alasdair Naylor head of research and Marie Lossky director of business development and intellectual property
Locus Pharmaceuticals Inc., of Blue Bell, Pa., named Jamie Freedman chief medical officer and vice president of clinical research and regulatory affairs
MedImmune Inc., of Gaithersburg, Md., appointed Alexander Zukiwski senior vice president of clinical research...and Timothy Maines vice president of corporate quality assurance
Synvista Therapeutics Inc., of Montvale, N.J., appointed Carl Mendel vice president of clinical development and chief medical officer...VLST Corp., of Seattle, appointed Consuelo Blosch vice president of clinicaland regulatory and Dan Allison senior director of therapeutic design
Alba Therapeutics Corp., of Baltimore, appointed Betsy Van Parijs senior vice president of clinical development and medical affairs...Egalet A/S, of Copenhagen, Denmark, named Michael Fiorini chairman and appointed Peter Nordkild CEO...plc, of Dublin, Ireland, named Jonas Frick and Giles Kerr nonexecutive directors
Cytochroma Inc., of Markham, Ontario, named Joel Z. Melnick vice president of clinicaland regulatory affairs...MAP Pharmaceuticals Inc., of Mountain View, Calif., named Stephen B. Shrewsbury chief medical officer and Shashidhar Kori vice president of clinical development
Alpha Innotech Corp., of San Leandro, Calif., named Joseph D. Keegan and Gus E. Davis to its board of directors...Gene Logic Inc., of Gaithersburg, Md., appointed Stephen R. Donahue senior vice president of clinical development
The company also named Keane and Elliot M. Maza to its board of directors...Naryx Pharma Inc., of Santa Barbara, Calif., appointed Andy Strayer vice president of clinical operations and medical affairs
Cougar Biotechnology Inc., of Los Angeles, appointed Arturo Molina senior vice president of clinical research and development, and Christopher Haqq senior director of clinical research and development
Synta Pharmaceuticals Corp., of Lexington, Mass., hired Anthony Williams as vice president of clinical research and Mary Drummond as director of commercial development for oncology...and Eldon Smith, vice president, scientific affairs and director, will assume all responsibilities of the position of chief medical officer and head of cardiovascular development
Medgenics, of Misgav, Israel, appointed Ehud Shoshani vice president of clinical affairs